AR043848A1 - Procedimiento para preparar la fenilamida del acido 5-(4- fluorofenil)-1-[2-((2r,4r)-4-hidroxi-6-oxo-tetrahidropiran-2- il) etil]-2-isopropil-4-fenil-1h-pirrol-3-carboxilico e intermediarios de sintesis. - Google Patents
Procedimiento para preparar la fenilamida del acido 5-(4- fluorofenil)-1-[2-((2r,4r)-4-hidroxi-6-oxo-tetrahidropiran-2- il) etil]-2-isopropil-4-fenil-1h-pirrol-3-carboxilico e intermediarios de sintesis.Info
- Publication number
- AR043848A1 AR043848A1 ARP040101212A ARP040101212A AR043848A1 AR 043848 A1 AR043848 A1 AR 043848A1 AR P040101212 A ARP040101212 A AR P040101212A AR P040101212 A ARP040101212 A AR P040101212A AR 043848 A1 AR043848 A1 AR 043848A1
- Authority
- AR
- Argentina
- Prior art keywords
- formula
- compound
- tetrahidropiran
- fluorophenil
- carboxilico
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D207/33—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D207/337—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D207/325—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
- C07D207/327—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Pyrrole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Reivindicación 1: Un procedimiento para preparar un compuesto de fórmula (1) comprendiendo (a) poner en contacto en un disolvente opcionalmente en presencia de un ácido de Lewis un compuesto de fórmula (2) con en compuesto de fórmula (7), en la que M es SiCl3, SiMe3, B(OH)2, CuLi, MgBr, ZnBr, InBr, SnBr3, en los que R3 es alquilo C1-6, para proporcionar un compuesto de fórmula (3); (b) convertir el compuesto de fórmula (3) en un éster de acriloilo de fórmula (4) en presencia de una base usando el compuesto de fórmula (8), en la que X es Cl, Br, I, o el compuesto de fórmula (9), y R es H, alquilo (C1-6), o fenilo, o un equivalente de éster activado con acriloilo; (c) poner en contacto en un disolvente el éster de acriloilo (4) con un catalizador para proporcionar 5,6-dihidropiran-2-ona (5); (d) convertir el compuesto de fórmula (5) a un compuesto de fórmula (6) mediante la adición 1,4 facial selectiva de alcohol alilico o bencílico; y (e) eliminar el resto alilo o bencilo en el compuesto de fórmula (6) mediante hidrogenólisis para proporcionar un compuesto de fórmula (1).
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US46261303P | 2003-04-14 | 2003-04-14 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR043848A1 true AR043848A1 (es) | 2005-08-17 |
Family
ID=33159855
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP040101212A AR043848A1 (es) | 2003-04-14 | 2004-04-12 | Procedimiento para preparar la fenilamida del acido 5-(4- fluorofenil)-1-[2-((2r,4r)-4-hidroxi-6-oxo-tetrahidropiran-2- il) etil]-2-isopropil-4-fenil-1h-pirrol-3-carboxilico e intermediarios de sintesis. |
Country Status (16)
Country | Link |
---|---|
US (1) | US20060205804A1 (es) |
EP (1) | EP1615883A1 (es) |
JP (1) | JP2006523670A (es) |
KR (1) | KR100780984B1 (es) |
CN (1) | CN1774421A (es) |
AR (1) | AR043848A1 (es) |
AU (1) | AU2004228463A1 (es) |
BR (1) | BRPI0409333A (es) |
CA (1) | CA2521903A1 (es) |
CL (1) | CL2004000777A1 (es) |
MX (1) | MXPA05011013A (es) |
RS (1) | RS20050760A (es) |
RU (1) | RU2337905C2 (es) |
TW (2) | TW200920745A (es) |
WO (1) | WO2004089894A1 (es) |
ZA (1) | ZA200507174B (es) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005012246A1 (en) * | 2003-07-25 | 2005-02-10 | Avecia Pharmaceuticals Limited | Process and intermediate compounds useful in the preparation of statins, particularly atorvastatin |
GB0514612D0 (en) * | 2005-07-15 | 2005-08-24 | Sasol Technology Uk Ltd | The use of a phosphorus containing ligand and a cyclic organic ligand in a metathesis catalyst |
WO2011028309A1 (en) | 2009-09-04 | 2011-03-10 | University Of Toledo | PROCESSES FOR PRODUCING OPTICALLY PURE β-LACTONES FROM ALDEHYDES AND COMPOSITIONS PRODUCED THEREBY |
JP5184565B2 (ja) * | 2010-03-10 | 2013-04-17 | 独立行政法人科学技術振興機構 | 水系溶媒中での含窒素化合物の製造方法 |
CN101892276B (zh) * | 2010-06-12 | 2012-11-21 | 郝志艳 | 一种阿托伐他汀钙化合物及其新方法 |
CN104356118B (zh) * | 2014-10-17 | 2017-03-22 | 上海应用技术学院 | 多取代吡咯类他汀内酯脱水化合物及其用途 |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4681893A (en) * | 1986-05-30 | 1987-07-21 | Warner-Lambert Company | Trans-6-[2-(3- or 4-carboxamido-substituted pyrrol-1-yl)alkyl]-4-hydroxypyran-2-one inhibitors of cholesterol synthesis |
US5216174A (en) * | 1988-02-22 | 1993-06-01 | Warner-Lambert Co. | Process for trans-6-[12-(substituted-pyrrol-1-yl)alkyl]pyran-2-one inhibitors of cholesterol synthesis |
US5245047A (en) * | 1988-02-22 | 1993-09-14 | Warner-Lambert Company | Process for trans-6-[2-(substituted-pyrrol-1-yl)alkyl]pyran-2-one inhibitors of cholesterol synthesis |
US5097045A (en) * | 1989-02-01 | 1992-03-17 | Warner-Lambert Company | Process for trans-6-[2-(substituted-pyrrol-1-yl)alkyl]pyran-2-one inhibitors of cholesterol synthesis |
US5124482A (en) * | 1988-02-22 | 1992-06-23 | Warner-Lambert Company | Process for trans-6-(2-substituted-pyrrol-1-yl)alkyl)pyran-2-one inhibitors of cholesterol synthesis |
US5149837A (en) * | 1988-02-22 | 1992-09-22 | Warner-Lambert Company | Process for trans-6-[2-(substituted-pyrrol-1-yl)alkyl]pyran-2-one inhibitors of cholesterol synthesis |
US5003080A (en) * | 1988-02-22 | 1991-03-26 | Warner-Lambert Company | Process for trans-6-(2-(substituted-pyrrol-1-yl)alkyl)pryan-2-one inhibitors of cholesterol synthesis |
FI94339C (fi) * | 1989-07-21 | 1995-08-25 | Warner Lambert Co | Menetelmä farmaseuttisesti käyttökelpoisen /R-(R*,R*)/-2-(4-fluorifenyyli)- , -dihydroksi-5-(1-metyylietyyli)-3-fenyyli-4-/(fenyyliamino)karbonyyli/-1H-pyrroli-1-heptaanihapon ja sen farmaseuttisesti hyväksyttävien suolojen valmistamiseksi |
US5103024A (en) * | 1990-10-17 | 1992-04-07 | Warner-Lambert Company | Process for the synthesis of (4r-cis)-1,1-dimethylethyl 6-cyanomethyl-2,2-dimethyl-1,3-dioxane-4-acetate |
US5248793A (en) * | 1990-10-17 | 1993-09-28 | Warner-Lambert Company | Process for the synthesis of (4R-cis)-1,1-dimethylethyl 6-iodomethyl or 6-(phenyl-substituted)sulfonyloxymethyl-2,2-dimethyl-1,3-dioxane-4-acetate |
US5155251A (en) * | 1991-10-11 | 1992-10-13 | Warner-Lambert Company | Process for the synthesis of (5R)-1,1-dimethylethyl-6-cyano-5-hydroxy-3-oxo-hexanoate |
US5298627A (en) * | 1993-03-03 | 1994-03-29 | Warner-Lambert Company | Process for trans-6-[2-(substituted-pyrrol-1-yl)alkyl]pyran-2-one inhibitors of cholesterol synthesis |
HRP960313B1 (en) * | 1995-07-17 | 2002-08-31 | Warner Lambert Co | Form iii crystalline (r- (r*, r*)-2- (4-fluorophenyl) -beta-delta-hydroxy-5-(1-methylethyl) -3-phenyl-4- ((phenylamino) carbonyl -1h-pyrrole-1-heptanoic acid calcium salt (2:1) |
CZ294108B6 (cs) * | 1995-07-17 | 2004-10-13 | Warner@Lambertácompany | Krystalická forma I hydrátu atorvastatinuŹ tj@ semivápenaté soli kyseliny [R@}RgŹRgB]@}@fluorfenylB@betaŹdelta@dihydroxy@Q@}�@methylethylB@fenyl[}fenylaminoBkarbonyl]@�H@pyrrol@�@heptanové |
US6087511A (en) * | 1996-07-16 | 2000-07-11 | Warner-Lambert Company | Process for the production of amorphous [R-(R*,R*)]-2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl )-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid) calcium salt (2:1) |
IL127058A (en) * | 1996-07-29 | 2001-07-24 | Warner Lambert Co | Process for the synthesis of protected esters of acid (S) - 4,3 dehydroxybutyric |
US6476235B2 (en) * | 2001-01-09 | 2002-11-05 | Warner-Lambert Company | Process for the synthesis of 5-(4-fluorophenyl)-1-[2-((2R,4R)-4-hydroxy-6-oxo-tetrahydro-pyran-2-yl)-ethyl]-2-isopropyl-4-phenyl-1H-pyrrole-3-carboxylic acid phenylamide |
CA2494269A1 (en) * | 2002-08-06 | 2004-02-19 | Warner-Lambert Company Llc | Process for preparing 5-(4-fluorophenyl)-1-[2-((2r,4r)-4-hydroxy -6-oxo-tetrahydro-pyran-2-yl)ethyl]-2-isopropyl-4-phenyl-1h-pyrrole-3-carboxylic acid phenylamide |
-
2004
- 2004-03-31 WO PCT/IB2004/001120 patent/WO2004089894A1/en active Application Filing
- 2004-03-31 RU RU2005131853/04A patent/RU2337905C2/ru not_active IP Right Cessation
- 2004-03-31 US US10/552,747 patent/US20060205804A1/en not_active Abandoned
- 2004-03-31 CN CNA2004800100752A patent/CN1774421A/zh active Pending
- 2004-03-31 EP EP04724674A patent/EP1615883A1/en not_active Withdrawn
- 2004-03-31 AU AU2004228463A patent/AU2004228463A1/en not_active Abandoned
- 2004-03-31 RS RSP-2005/0760A patent/RS20050760A/sr unknown
- 2004-03-31 KR KR1020057019419A patent/KR100780984B1/ko not_active IP Right Cessation
- 2004-03-31 BR BRPI0409333-0A patent/BRPI0409333A/pt not_active IP Right Cessation
- 2004-03-31 JP JP2006506465A patent/JP2006523670A/ja not_active Withdrawn
- 2004-03-31 CA CA002521903A patent/CA2521903A1/en not_active Abandoned
- 2004-03-31 MX MXPA05011013A patent/MXPA05011013A/es active IP Right Grant
- 2004-04-08 CL CL200400777A patent/CL2004000777A1/es unknown
- 2004-04-12 AR ARP040101212A patent/AR043848A1/es not_active Application Discontinuation
- 2004-04-12 TW TW097134271A patent/TW200920745A/zh unknown
- 2004-04-12 TW TW093110141A patent/TW200426149A/zh unknown
-
2005
- 2005-09-07 ZA ZA200507174A patent/ZA200507174B/en unknown
Also Published As
Publication number | Publication date |
---|---|
KR20050110042A (ko) | 2005-11-22 |
TW200426149A (en) | 2004-12-01 |
RS20050760A (sr) | 2008-04-04 |
WO2004089894A1 (en) | 2004-10-21 |
RU2337905C2 (ru) | 2008-11-10 |
ZA200507174B (en) | 2006-10-25 |
AU2004228463A1 (en) | 2004-10-21 |
TW200920745A (en) | 2009-05-16 |
KR100780984B1 (ko) | 2007-11-29 |
US20060205804A1 (en) | 2006-09-14 |
CN1774421A (zh) | 2006-05-17 |
CL2004000777A1 (es) | 2005-03-04 |
RU2005131853A (ru) | 2006-03-10 |
WO2004089894A8 (en) | 2005-12-01 |
BRPI0409333A (pt) | 2006-04-25 |
EP1615883A1 (en) | 2006-01-18 |
JP2006523670A (ja) | 2006-10-19 |
MXPA05011013A (es) | 2005-12-12 |
CA2521903A1 (en) | 2004-10-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR035680A1 (es) | Procedimiento para la sintesis de fenilamida del acido 5-(4-fluorofenil)-1-[2-((2r,4r)-hidroxi-6-oxotetrahidropiran-2-il)etil]-2-isopropil-4-fenil-1h-pirrol-3-carboxilico y compuestos utiles en dicho procedimiento | |
BRPI0415855B1 (pt) | Processo para preparação de ésteres de ácido 2-dihalogenacil-3-amino-acrílico e ésteres de ácido 3-dihalogeno-metil-pirazol-4-carboxílico | |
RS53398B (en) | PROCEDURE FOR OBTAINING AMINO CROTONYL UNITS | |
RU2003104825A (ru) | Способ получения производных 2-(6-замещенной-1, 3-диоксан-4-ил) укусной кислоты | |
RS52163B (en) | DERIVATES THE BICYCLESTER | |
EA199800290A1 (ru) | (метилсульфонил) фенил-2-(5н)-фураноны в качестве ингибиторов циклооксигеназы-2 | |
ATE402173T1 (de) | Stereoselektive synthese bestimmter trifluormethylsubstituierter alkohole | |
CO5700779A2 (es) | Un proceso para la preparación de oxi-(1h)-quinolin-2-onas 5-(haloacetil)-8-sustituidas | |
AR043848A1 (es) | Procedimiento para preparar la fenilamida del acido 5-(4- fluorofenil)-1-[2-((2r,4r)-4-hidroxi-6-oxo-tetrahidropiran-2- il) etil]-2-isopropil-4-fenil-1h-pirrol-3-carboxilico e intermediarios de sintesis. | |
RS50663B (sr) | Postupci za dobijanje 3-o-zaštićenih morfinona i 3-o-zaštićenih morfinon dienol karboksilata | |
NO20024241D0 (no) | Fremgangsmåte for fremstilling av citalopram | |
EA200400129A1 (ru) | Способ получения периндоприла, его аналогов и солей с использованием 2,5-диоксооксазолидиновых промежуточных соединений | |
IS2477B (is) | Aðferð til að framleiða díoxanediksýruestera | |
FR2829134A1 (fr) | Procede de preparation de (meth) acrylates d'alkylimidazolidone | |
DE60119099D1 (de) | Herstellung von alicyclischen (meth)allylestern für kunststofflinsenzusammensetzungen | |
AR040777A1 (es) | Procedimiento para preparar fenilamida del acido 5-( 4-fluorofenil)-1-(2((2r,4r)-4-hidroxi-6-oxo-tetrahidro-piran-2il) etil) -2-isopropil-4-fenil-1-h-pirrol-3- carboxilico | |
IL174002A0 (en) | Process for producing high purity 3,5-dihydroxy-6-heptenoic acid derivative | |
ES2209674T1 (es) | Procedimiento mejorado para la preparacion de intermediarios de gabapentina. | |
RU2007110644A (ru) | Способ получения диарилциклоалкилпроизводных | |
PA8525601A1 (es) | Profarmacos de (3s,4s)-4-bencil-1-[2-(4-hidroxi-bencenosulfonil)-etil]-piperidin-3-ol | |
ES2191587T3 (es) | Procedimiento para la preparacion de derivados de 4-fenil-piperidina 3-sustituida. | |
TW200635981A (en) | Ring-opening polymerization and activated carbon catalyst for ring-opening polymerization | |
JP2004217575A5 (es) | ||
EP1364933A4 (en) | OPTICAL RESOLUTION SYSTEM AND OPTICAL ALCOHOL RESOLUTION METHOD USING THE SAME | |
ATE325090T1 (de) | Mischungen von schwefelsäureestern |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |